Merck is in talks to buy cancer drug developer Revolution Medicines in a deal that may be worth $28 billion to $32 billion ...

The Readout heads to the J.P. Morgan Healthcare Conference next week, which means it will hit your inboxes in the afternoon ...

Today’s lineup features a stark estimate of how Medicaid eligibility restrictions might lead to more cancer deaths, a look at ...

In fact, the pared-down U.S. vaccine schedule now aims to protect children against fewer diseases than all but one of the 20 ...

The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.

A New York law grants patients the right to request aid in dying. But do the clinicians who guide them through that decision ...

Hoping to catch serious illnesses early, more Americans are ordering lab tests online, but their doctors don't know what to ...

New dietary guidelines limit saturated fats to 10% of total calories, but also encourage full-fat dairy, red meat, and beef ...

WASHINGTON — The House voted 230 to 196 to pass a three-year extension of enhanced Affordable Care Act premium subsidies, ...

Why will pharma CEOs be greeted warmly in San Francisco next week? And who will buy Revolution Medicines? All that and more ...

Millions of people, including me and possibly you, are already asking ChatGPT questions about health. Still others are ...

A U.S. appeals court panel has refused to allow the Trump administration to proceed with a pilot initiative tied to a ...